Mercaptopurine and Uceris drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mercaptopurine (mercaptopurine) and Uceris (budesonide). Common drug interactions include drug ineffective among females and frequent bowel movements among males.

The phase IV clinical study analyzes what interactions people have when they take Mercaptopurine and Uceris. It is created by eHealthMe based on reports of 44 people who take the same drugs from the FDA, and is updated regularly.

What is Mercaptopurine?

Mercaptopurine has active ingredients of mercaptopurine. It is often used in crohn's disease. eHealthMe is studying from 23,013 Mercaptopurine users. Check the latest studies of Mercaptopurine.

What is Uceris?

Uceris has active ingredients of budesonide. It is often used in ulcerative colitis. eHealthMe is studying from 1,721 Uceris users. Check the latest studies of Uceris.



On Jul, 12, 2026

44 people who take Mercaptopurine and Uceris together, and have interactions are studied.

Mercaptopurine and Uceris drug interactions.

What are the common drug interactions of Mercaptopurine and Uceris, by gender? *:

female:

  1. Drug ineffective
  2. Asthenia (weakness)
  3. Drug effect decreased
  4. Gastric ulcer perforation (stomach hole due to ulcer)
  5. Haematochezia (passage of stools containing blood)
  6. Myalgia (muscle pain)
  7. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  8. Abnormal faeces (abnormal stool)
  9. Antinuclear antibody positive
  10. Autoimmune disorder (a condition in which the immune system attacks the body's normal substances and tissue)

male:

  1. Frequent bowel movements
  2. Fatigue (feeling of tiredness)
  3. White blood cell count decreased
  4. Defaecation urgency (a sudden compelling urge to defecate)
  5. Diarrhoea
  6. Injection site erythema (redness at injection site)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  9. Cerebral haemorrhage (bleeding within the brain)
  10. Dizziness

What are the common drug interactions of Mercaptopurine and Uceris, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Device related infection
  2. Small intestinal obstruction (blockage in small intestine)

20-29:

  1. Acne (skin problems that cause pimples)
  2. Fistula discharge (discharge from abnormal passage of structure/organ)
  3. Nausea (feeling of having an urge to vomit)
  4. Rectal abscess (pus in rectum)
  5. Subcutaneous abscess
  6. Vomiting
  7. Wound haemorrhage (bleeding wound)
  8. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  9. Anaemia (lack of blood)
  10. Asthenia (weakness)

30-39:

  1. Frequent bowel movements
  2. Body temperature increased
  3. Cellulitis (infection under the skin)
  4. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  5. Fatigue (feeling of tiredness)
  6. Feeling hot
  7. Haematochezia (passage of stools containing blood)
  8. White blood cell count decreased
  9. Acne (skin problems that cause pimples)
  10. Nausea (feeling of having an urge to vomit)

40-49:

  1. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  2. Abnormal faeces (abnormal stool)
  3. Flatulence (flatus expelled through the anus)
  4. Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
  5. Decreased appetite
  6. Diarrhoea
  7. Fatigue (feeling of tiredness)
  8. Hangover
  9. Hypersomnia (excessive daytime sleepiness (eds))
  10. Injection site erythema (redness at injection site)

50-59:

  1. Gastric ulcer perforation (stomach hole due to ulcer)
  2. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  3. Cataract (clouding of the lens inside the eye)
  4. Drug ineffective

60+:

  1. Drug ineffective
  2. Defaecation urgency (a sudden compelling urge to defecate)
  3. Pneumonia
  4. Weight decreased
  5. Breast cancer
  6. Colitis (inflammation of colon)
  7. Flatulence (flatus expelled through the anus)
  8. Injection site pain
  9. Lupus-like syndrome (a disease symptom matches with lupus an immune disease)
  10. Maculopathy (a condition or disease of the macula, the small spot in the retina where vision is keenest)

What are the existing conditions these people have? *

  1. Pain: 6 people, 13.64%
  2. Nausea (feeling of having an urge to vomit): 4 people, 9.09%
  3. Herpes Zoster: 4 people, 9.09%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 9.09%
  5. Stress And Anxiety: 3 people, 6.82%
  6. Multiple Allergies (allergy to multiple agents): 3 people, 6.82%
  7. Hypersensitivity: 3 people, 6.82%

* Approximation only. Some reports may have incomplete information.

Do you take Mercaptopurine and Uceris?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Mercaptopurine and Uceris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Mercaptopurine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Uceris:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Mercaptopurine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Uceris and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on mercaptopurine and budesonide (the active ingredients of Mercaptopurine and Uceris, respectively), and Mercaptopurine and Uceris (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: